Search Press releases

19 Nov 2024

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity

Read More
18 Nov 2024

Transparency notification BlackRock, Inc.

Read More
18 Nov 2024

Transparency notification BlackRock, Inc.

Read More
14 Nov 2024

New BIMZELX[®] (bimekizumab-bkzx) data at ACR Convergence 2024 highlights UCB’s efforts to deliver differentiated care for patients with psoriatic arthritis and axial spondyloarthritis

Read More
12 Nov 2024

Transparency notification BlackRock, Inc.

Read More
8 Nov 2024

Transparency notification BlackRock, Inc.

Read More

Stay up-to-date on the latest news and information from UCB